Menu
Back to Journals » Clinical Audit » Volume 5
An audit of patient inclusion in retinopathy of prematurity (ROP) screening and whether discharge summaries contained ROP information with suggestions for improvement
Authors Harding SA , Abdullah M, Adams G
Received 15 January 2013
Accepted for publication 4 March 2013
Published 13 June 2013 Volume 2013:5 Pages 57—60
DOI https://doi.org/10.2147/CA.S42804
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Samantha A Harding,1 Mohamad Abdullah,1,2 Gillian Adams1,2
1Great Ormond Street Hospital for Children, 2Moorfields Eye Hospital, London, UK
Abstract: In a busy neonatal unit with a number of very sick children it can be difficult to highlight those children requiring retinopathy of prematurity screening and to include this in the patient's discharge summary to ensure continuity of care. This audit looks at how efficiently children are included in the retinopathy of prematurity (ROP) screening programme at one tertiary referral unit and how well information is recorded in the discharge summary. A total of 185 infants were audited over two, 3-month periods with a sticker system for the notes devised between measurements. Re-audit showed improvement in the numbers included for ROP screening and the frequency with which ROP information was included in the discharge summaries. This simple, low cost system provides an effective method of ensuring optimum care for premature infants with ROP.
Keywords: neonatal unit, sticker, discharge summary
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.